Patrick Couvreur
#84,896
Most Influential Person Now
French pharmacologist
Patrick Couvreur's AcademicInfluence.com Rankings
Patrick Couvreurmedical Degrees
Medical
#827
World Rank
#1082
Historical Rank
Pharmacology
#51
World Rank
#70
Historical Rank
Download Badge
Medical
Patrick Couvreur's Degrees
- PhD Pharmaceutical Sciences Paris-Saclay University
- Doctorate Pharmacy Paris-Saclay University
Why Is Patrick Couvreur Influential?
(Suggest an Edit or Addition)According to Wikipedia, Patrick Couvreur, born 1950 in Schaerbeek , is a French pharmacologist who specialises in medical nanotechnology and is currently professor at the University of Paris-Sud. Couvreur was elected as a member into the National Academy of Engineering in 2015 for advances in nanomedicine and commercialization of targeted nanotechnology systems for cancer treatment.
Patrick Couvreur's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Stimuli-responsive nanocarriers for drug delivery. (2013) (4529)
- Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. (2010) (3227)
- Metal-organic frameworks in biomedicine. (2012) (3195)
- Nanoparticles in cancer therapy and diagnosis. (2002) (3049)
- Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. (2012) (1637)
- Nanocarriers’ entry into the cell: relevance to drug delivery (2009) (1364)
- BioMOFs: metal-organic frameworks for biological and medical applications. (2010) (919)
- Nanotechnology: Intelligent Design to Treat Complex Disease (2006) (861)
- Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. (2013) (744)
- Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. (2002) (629)
- Nanoparticles in drug delivery: past, present and future. (2013) (542)
- Design of folic acid-conjugated nanoparticles for drug targeting. (2000) (520)
- Nanocapsule technology: a review. (2002) (494)
- Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. (2003) (465)
- Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. (2005) (459)
- Polysaccharide-decorated nanoparticles. (2004) (437)
- Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery (2001) (429)
- Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties (1979) (425)
- Development of a new drug carrier made from alginate. (1993) (389)
- Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine (2018) (384)
- Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. (2000) (380)
- Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. (1999) (365)
- Controlled drug delivery with nanoparticles : current possibilities and future trends (1995) (364)
- New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier (1988) (361)
- Nanotheranostics for personalized medicine. (2016) (334)
- Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? (2005) (321)
- Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties (2005) (321)
- Design, Functionalization Strategies and Biomedical Applications of Targeted Biodegradable/Biocompatible Polymer‐Based Nanocarriers for Drug Delivery (2013) (319)
- Pharmacokinetics and Distribution of a Biodegradable Drug-carrier (1983) (315)
- Squalene: A natural triterpene for use in disease management and therapy. (2009) (306)
- Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. (2005) (286)
- Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. (2011) (284)
- Squalenoyl nanomedicines as potential therapeutics. (2006) (278)
- Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices. (2014) (272)
- Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. (2003) (260)
- Prodrug-based intracellular delivery of anticancer agents. (2011) (259)
- Nano- and microparticles for the delivery of polypeptides and proteins (1993) (256)
- Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. (2000) (255)
- Nanocapsules as carriers for oral peptide delivery (1990) (254)
- In depth analysis of the in vivo toxicity of nanoparticles of porous iron(III) metal–organic frameworks (2013) (253)
- Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. (2011) (252)
- Degradation of poly (isobutyl cyanoacrylate) nanoparticles. (1984) (252)
- Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. (2014) (244)
- II. Glutamine and glutamate. (2002) (236)
- Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting (2002) (227)
- Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles. (1982) (218)
- Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88A (2011) (204)
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. (2005) (202)
- "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. (2004) (201)
- Recent trends in the design of anticancer polymer prodrug nanocarriers (2014) (196)
- Study of emulsion stabilization by graft copolymers using the optical analyzer Turbiscan. (2003) (189)
- Squalenoyl Adenosine Nanoparticles provide Neuroprotection after Stroke and Spinal Cord Injury (2014) (188)
- Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. (1999) (187)
- The Design of Nanoparticles Obtained by Solvent Evaporation: A Comprehensive Study (2003) (183)
- Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. (2006) (180)
- A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity (2014) (176)
- Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. (2007) (175)
- Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. (1979) (175)
- Surface-engineered nanoparticles for multiple ligand coupling. (2003) (172)
- Nanocapsules: A new type of lysosomotropic carrier (1977) (171)
- Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. (1997) (171)
- Nanoparticulate systems for the delivery of antisense oligonucleotides. (2001) (169)
- Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. (1997) (166)
- Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents (2007) (166)
- Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells (2007) (163)
- Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. (1997) (163)
- Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length (1992) (159)
- A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection (2009) (156)
- Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. (1980) (156)
- Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity. (2018) (155)
- Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides (2000) (152)
- Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis (2000) (150)
- Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat (2002) (149)
- PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease. (2012) (148)
- Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles (1989) (147)
- Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. (1992) (147)
- Metallic colloid nanotechnology, applications in diagnosis and therapeutics. (2005) (146)
- Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system (2007) (145)
- Cyclodextrins for drug delivery (2010) (145)
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture. (1994) (138)
- New self-assembled nanogels based on host-guest interactions: characterization and drug loading. (2006) (136)
- In vitro model for the degradation of alkylcyanoacrylate nanoparticles. (1990) (135)
- Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading (1990) (134)
- Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen. (2009) (131)
- Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles (1992) (128)
- PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases (2001) (127)
- Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. (2005) (127)
- Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis (2004) (127)
- Cationic Vectors in Ocular Drug Delivery (2004) (127)
- I. Arginine : Free amino acids in human health and pathologies. Part 1 (2002) (126)
- Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. (1998) (126)
- Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles. (1982) (126)
- Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. (1980) (125)
- Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. (2011) (125)
- Polysaccharides Grafted with Polyesters: Novel Amphiphilic Copolymers for Biomedical Applications (2002) (124)
- Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease. (2012) (122)
- Pegylated Nanoparticles from a Novel Methoxypolyethylene Glycol Cyanoacrylate-Hexadecyl Cyanoacrylate Amphiphilic Copolymer (1998) (121)
- Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. (1986) (120)
- EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice. (2000) (118)
- A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types. (2007) (118)
- Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. (2009) (117)
- Fe3O4/chitosan nanocomposite for magnetic drug targeting to cancer (2012) (117)
- Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. (2009) (116)
- Lipid conjugated oligonucleotides: a useful strategy for delivery. (2012) (116)
- Squalenoylation: a generic platform for nanoparticular drug delivery. (2012) (116)
- Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines (2017) (116)
- Temperature-dependent rheological behavior of pluronic F-127 aqueous solutions (1987) (115)
- Novel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles (2003) (114)
- Nanotechnology for therapy and imaging of liver diseases. (2011) (113)
- The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats (1991) (112)
- Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides (1998) (112)
- Polyalkylcyanoacrylates as colloidal drug carriers. (1988) (112)
- Towards an Improved anti‐HIV Activity of NRTI via Metal–Organic Frameworks Nanoparticles (2013) (111)
- Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. (2007) (110)
- Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. (2003) (110)
- Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. (2008) (109)
- In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. (1984) (109)
- Palladium: a future key player in the nanomedical field? (2015) (108)
- Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. (2012) (104)
- Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives (1991) (104)
- Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. (1999) (104)
- Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery (2000) (104)
- Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma (2006) (101)
- A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles (2005) (100)
- Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells (2004) (100)
- A Smart Metal-Organic Framework Nanomaterial for Lung Targeting. (2017) (100)
- Liposomes and Nanoparticles in the Treatment of Intracellular Bacterial Infections (1991) (99)
- Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. (2002) (99)
- Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model. (2004) (97)
- Novel approaches to deliver gemcitabine to cancers. (2008) (97)
- Magnetically responsive microspheres for the pulsed delivery of insulin. (1988) (94)
- Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. (2001) (94)
- Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases. (1989) (92)
- High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. (2008) (91)
- Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. (2010) (90)
- Lipid prodrug nanocarriers in cancer therapy. (2015) (90)
- Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices (2011) (90)
- Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. (2011) (89)
- Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection (2015) (89)
- Novel Polyester-Polysaccharide Nanoparticles (2003) (89)
- Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides (1992) (88)
- Small-angle neutron and X-ray scattering from amphiphilic stimuli-responsive diamond-type bicontinuous cubic phase. (2007) (88)
- Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases (2006) (87)
- Porous metal organic framework nanoparticles to address the challenges related to busulfan encapsulation. (2011) (85)
- I. Arginine. (2002) (84)
- Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice (2008) (84)
- Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules. (1986) (83)
- Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. (1993) (82)
- Development of a nanoparticle controlled-release formulation for human use (1986) (81)
- Small-Angle X-ray Scattering Investigations of Biomolecular Confinement, Loading, and Release from Liquid-Crystalline Nanochannel Assemblies. (2012) (81)
- Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. (2000) (81)
- Radical Emulsion Polymerization of Alkylcyanoacrylates Initiated by the Redox System Dextran-Cerium(IV) under Acidic Aqueous Conditions (2003) (81)
- Spontaneous association of hydrophobized dextran and poly-beta-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug. (2007) (80)
- Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. (2009) (80)
- Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus. (1992) (80)
- Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. (2006) (79)
- Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate. (2004) (78)
- Ability of Doxorubicin-Loaded Nanoparticles to Overcome Multidrug Resistance of Tumor Cells After Their Capture by Macrophages (1999) (78)
- DNA/Fusogenic Lipid Nanocarrier Assembly: Millisecond Structural Dynamics. (2013) (78)
- Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization. (2013) (78)
- Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice (2008) (78)
- Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations (1990) (77)
- Novel self-assembling nanogels: stability and lyophilisation studies. (2007) (76)
- Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery (2017) (76)
- Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier. (2004) (75)
- Increased bone marrow toxicity of doxorubicin bound to nanoparticles. (1994) (75)
- Adsorption of Oligonucleotides onto Polyisohexylcyanoacrylate Nanoparticles Protects Them Against Nucleases and Increases Their Cellular Uptake (1994) (75)
- Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. (1996) (75)
- Nanoparticles as microcarriers for anticancer drugs (1990) (74)
- Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡ (1997) (74)
- New magnetic drug carrier (1983) (74)
- Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice (1988) (74)
- Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). (1997) (74)
- Visualization of Insulin-Loaded Nanocapsules: In Vitro and in Vivo Studies After Oral Administration to Rats (2003) (73)
- Cells involved in the capture of nanoparticles in hematopoietic organs. (1996) (73)
- Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel (1998) (73)
- Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. (2010) (73)
- Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer (1996) (73)
- Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles (2008) (72)
- Preclinical Toxicology (Subacute and Acute) and Efficacy of a New Squalenoyl Gemcitabine Anticancer Nanomedicine (2008) (72)
- A methodology to study intracellular distribution of nanoparticles in brain endothelial cells. (2005) (71)
- Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model. (2017) (71)
- Long-living intermediates during a lamellar to a diamond-cubic lipid phase transition: a small-angle X-ray scattering investigation. (2009) (70)
- Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. (1997) (69)
- Novel PEGylated Nanoassemblies Made of Self‐Assembled Squalenoyl Nucleoside Analogues (2008) (69)
- Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. (1998) (69)
- Interactions of anticancer drugs with biomembranes: what can we learn from model membranes? (2014) (69)
- Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents (2020) (69)
- Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. (2011) (68)
- Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate (1993) (68)
- Facile Synthesis of Innocuous Comb-Shaped Polymethacrylates with PEG Side Chains by Nitroxide-Mediated Radical Polymerization in Hydroalcoholic Solutions (2010) (68)
- Insulin‐loaded nanocapsules for oral administration: In vitro and in vivo investigation (2000) (67)
- Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. (1999) (66)
- Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy (2014) (66)
- Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. (2013) (66)
- Alkylcyanoacrylate drug carriers. I : Physicochemical characterization of nanoparticles with different alkyl chain length (1992) (66)
- An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance (2015) (65)
- Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. (1992) (65)
- Attachment of antibiotics to nanoparticles: preparation, drug-release and antimicrobial activity in vitro (1987) (65)
- siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma (2007) (64)
- GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness. (2018) (63)
- Role of gut macrophages in mice orally contaminated with scrapie or BSE. (2005) (63)
- Detailed structure of diamond-type lipid cubic nanoparticles. (2006) (63)
- Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres (1997) (62)
- First peptide/protein PEGylation with functional polymers designed by nitroxide-mediated polymerization (2011) (62)
- Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. (2001) (62)
- Nanoparticles as carriers for growth hormone releasing factor (1991) (62)
- Novel composite core-shell nanoparticles as busulfan carriers. (2006) (61)
- Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. (2008) (60)
- Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. (2007) (60)
- A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer. (2017) (60)
- Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions. (2004) (59)
- Spleen Capture of Nanoparticles: Influence of Animal Species and Surface Characteristics (2004) (59)
- Advanced nanomedicines for the treatment of inflammatory diseases (2020) (58)
- Physico-chemical characterization of polysaccharide-coated nanoparticles. (2005) (58)
- Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats (1992) (57)
- Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. (2009) (57)
- Submicron Cationic Emulsions as a New Delivery System for Oligonucleotides (2004) (57)
- Pharmacokinetics and Biodistribution of Oligonucleotide Adsorbed onto Poly(isobutylcyanoacrylate) Nanoparticles After Intravenous Administration in Mice (2004) (57)
- Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. (1995) (57)
- Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs. (2008) (57)
- A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery (2017) (57)
- Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers. (2007) (57)
- Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy. (2014) (56)
- Measurement of the Density of Polymeric Nanoparticulate Drug Carriers by Isopycnic Centrifugation (1999) (56)
- Dynamic control of nanofluidic channels in protein drug delivery vehicles (2008) (55)
- Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF). (1998) (55)
- Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging. (2010) (55)
- Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles. (1996) (55)
- Efficient “green” encapsulation of a highly hydrophilic anticancer drug in metal–organic framework nanoparticles (2015) (54)
- Splenic Trapping of Nanoparticles: Complementary Approaches for In Situ Studies (1997) (54)
- Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. (2011) (53)
- Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release (1991) (53)
- Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. (1998) (52)
- SG1 Nitroxide-Mediated Polymerization of Isoprene: Alkoxyamine Structure/Control Relationship and α,ω–Chain-End Functionalization (2011) (52)
- Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy. (2013) (52)
- Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules. (2006) (51)
- Nanotechnologies for the treatment of colon cancer: From old drugs to new hope. (2016) (51)
- Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages. (2006) (51)
- New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide. (2010) (50)
- In vivo behavior of MIL-100 nanoparticles at early times after intravenous administration. (2016) (50)
- Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method (1997) (50)
- Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation. (2015) (50)
- Comblike Polymethacrylates with Poly(ethylene glycol) Side Chains via Nitroxide-Mediated Controlled Free-Radical Polymerization (2008) (49)
- Nanomedicines for Pediatric Cancers. (2018) (49)
- Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis (1991) (48)
- Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (w1/o)w2 emulsion solvent evaporation method (1994) (48)
- Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine (2009) (48)
- Design attributes of long-circulating polymeric drug delivery vehicles. (2015) (47)
- Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. (1999) (47)
- A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine (2019) (47)
- Nanoencapsulation of a crystalline drug. (2005) (47)
- Improving the Antitumor Activity of Squalenoyl‐Paclitaxel Conjugate Nanoassemblies by Manipulating the Linker between Paclitaxel and Squalene (2013) (47)
- PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma. (2016) (46)
- Comproportionation versus Disproportionation in the Initiation Step of Cu(0)-Mediated Living Radical Polymerization (2012) (46)
- Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens. (2002) (46)
- Some parameters influencing cytotoxicity of free doxorubicin and doxorubicin-loaded nanoparticles in sensitive and multidrug resistant leucemic murine cells: incubation time, number of nanoparticles per cell (1994) (46)
- Intracellular targeting of antibiotics by means of biodegradable nanoparticles (1992) (44)
- Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. (1991) (44)
- Freeze-Drying of Composite Core-Shell Nanoparticles (2006) (44)
- Precise Engineering of Multifunctional PEGylated Polyester Nanoparticles for Cancer Cell Targeting and Imaging (2014) (44)
- A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus (2015) (44)
- Tissue Distribution of [actinomycin-h-3 D Adsorbed On Polybutylcyanoacrylate Nanoparticles (1980) (44)
- New Core-Shell Nanoparticules for the Intravenous Delivery of siRNA to Experimental Thyroid Papillary Carcinoma (2010) (43)
- Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide. (2006) (43)
- Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle Technology (2000) (43)
- Simple and efficient copper metal-mediated synthesis of alkoxyamine initiators (2011) (43)
- Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. (2001) (43)
- Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics (1992) (43)
- Nanomedicines: A New Approach for the Treatment of Serious Diseases (2007) (43)
- pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. (1998) (42)
- Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. (2014) (42)
- Polymeric Micro- and Nanoparticles as Drug Carriers (2001) (42)
- Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF) (1992) (41)
- Uptake of Nanoparticles by Rat Glomerular Mesangial Cells in Vivo and in Vitro (1994) (41)
- Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery. (2013) (41)
- Molecular Weights of Free and Drug-Loaded Nanoparticles (2004) (41)
- Light sheet fluorescent microscopy versus confocal microscopy: in quest of a suitable tool to assess drug and nanomedicine penetration into multicellular tumor spheroids. (2019) (41)
- Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice. (2000) (41)
- Synthesis of Highly Functionalized Poly(alkyl cyanoacrylate) Nanoparticles by Means of Click Chemistry (2008) (41)
- Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres. (2000) (41)
- Acute Renal Toxicity of Doxorubicin (Adriamycin)-Loaded Cyanoacrylate Nanoparticles (2004) (40)
- On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance (1996) (40)
- A comprehensive study of the spontaneous formation of nanoassemblies in water by a "lock-and-key" interaction between two associative polymers. (2011) (40)
- Intracellular Visualization of Ampicillin-Loaded Nanoparticles in Peritoneal Macrophages Infected in Vitro with Salmonella typhimurium (2004) (40)
- Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study. (2010) (40)
- Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha. (2008) (40)
- Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. (1999) (39)
- Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells. (1998) (39)
- A new approach for the characterization of insoluble amphiphilic copolymers based on their emulsifying properties (2004) (38)
- pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. (2000) (38)
- Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles. (2013) (38)
- Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. (2011) (38)
- Toxicity of metal-organic framework nanoparticles: from essential analyses to potential applications. (2022) (37)
- Polymer-based nanoparticles for the delivery of nucleoside analogues. (2006) (37)
- The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium. (1994) (37)
- BioMOFs: Metal—Organic Frameworks for Biological and Medical Applications (2011) (37)
- Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP). in vitro and in vivo studies. (1994) (36)
- Therapeutic Potentialities of EWS‐Fli‐1 mRNA‐Targeted Vectorized Antisense Oligonucleotides (2003) (36)
- Implant Materials in Biofunction: Advances in Biomaterials 8, Editors: C. de Putter, G.L. Lange, K. de Groot and A.J.C. Lee Elsevier, Amsterdam, 1988, pp 522, DFL 365.00 (1989) (36)
- Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models (2007) (36)
- Oligonucleotides Targeted Against a Junction Oncogene Are Made Efficient by Nanotechnologies (2003) (36)
- Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms (2008) (36)
- Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells. (2017) (35)
- Phospholipid hydrolysis in a pharmaceutical emulsion assessed by physicochemical parameters and a new analytical method. (2005) (35)
- Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles (1994) (35)
- ‘Green’ fluorine-free mesoporous iron(III) trimesate nanoparticles for drug delivery (2013) (35)
- Interaction of an anticancer drug, gemcitabine, with phospholipid bilayers (2009) (35)
- Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms. (1998) (34)
- Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain Barrier (2015) (34)
- Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres. (1998) (34)
- In vitro evaluation of nanoparticles spleen capture. (1999) (34)
- Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. (2010) (34)
- Quantification of fumaric acid in liver, spleen and urine by high-performance liquid chromatography coupled to photodiode-array detection. (2011) (34)
- Protein driven patterning of self-assembled cubosomic nanostructures: long oriented nanoridges. (2005) (34)
- Protection of insulin from enzymatic degradation by its association to liposomes (1985) (33)
- Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies. (2013) (33)
- Use of solvent effects to improve control over nitroxide-mediated polymerization of isoprene. (2012) (33)
- A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles. (2003) (33)
- Nanoplumbers: biomaterials to fight cardiovascular diseases (2017) (33)
- Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV. (2007) (33)
- A Polysorbate-Based Non-Ionic Surfactant Can Modulate Loading and Release of β-Lactoglobulin Entrapped in Multiphase Poly(DL-Lactide-co-glycolide) Microspheres (1999) (32)
- Structural characterization of ultrasmall superparamagnetic iron oxide (USPIO) particles in aqueous suspension by energy dispersive X-ray diffraction (EDXD). (2006) (32)
- Vidarabine-Loaded Nanoparticles: A Physicochemical Study (1990) (32)
- Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues. (2010) (31)
- Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice (2013) (31)
- Cell cultures for the assessment of toxicity and uptake of polymeric particulate drug carriers (1993) (31)
- Nanoparticles: heating tumors to death? (2011) (31)
- NANOPARTICLES : PREPARATION AND CHARACTERIZATION (1996) (31)
- On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level. (1997) (31)
- Peptide conjugation: before or after nanoparticle formation? (2014) (31)
- Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. (1989) (30)
- Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies. (2015) (30)
- Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone. (1989) (30)
- Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with streptococcus pneumoniae. (2000) (30)
- Factors influencing the oligonucleotides release from O-W submicron cationic emulsions. (2001) (29)
- Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum (1996) (29)
- Drug Targeting by Polyalkylcyanoacrylate Nanoparticles Is Not Efficient Against Persistent Salmonella (1998) (29)
- Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells (2017) (29)
- Sorptive properties of antibodies onto cyanoacrylic nanoparticles (1988) (29)
- Facile synthesis of multicompartment micelles based on biocompatible poly(3-hydroxyalkanoate). (2013) (29)
- Enhancing the tolerance of poly(isobutylcyanoacrylate) nanoparticles with a modular surface design. (2007) (28)
- Liposomally-entrapped ATP: improved efficiency against experimental brain ischemia in the rat. (1987) (28)
- Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer (2015) (28)
- How can nanomedicines overcome cellular-based anticancer drug resistance? (2016) (28)
- Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles. (2019) (28)
- Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease. (2013) (27)
- Novel self assembling nanoparticles for the oral administration of fondaparinux: Synthesis, characterization and in vivo evaluation (2014) (27)
- PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus. (2019) (26)
- Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies (2010) (26)
- Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages (2013) (26)
- Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver. (1993) (26)
- Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo results. (2016) (26)
- Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (2020) (26)
- Study of the Influence of Several Stabilizing Agents on the Entrapment and InVitro Release of pBC 264 from Poly(Lactide-Co-Glycolide) Microspheres Prepared by a W/O/W Solvent Evaporation Method (1996) (26)
- On shelf stability of freeze-dried poly(methylidene malonate 2.1.2) nanoparticles (1997) (25)
- Simple Synthesis of Cladribine-Based Anticancer Polymer Prodrug Nanoparticles with Tunable Drug Delivery Properties (2016) (25)
- Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. (2011) (25)
- Efficiency of liposomal ATP in cerebral ischemia: Bioavailability features (1991) (25)
- Establishment of an in vitro model expressing the folate receptor for the investigation of targeted delivery systems (2005) (25)
- Significant Tumor Growth Inhibition from Naturally Occurring Lipid-Containing Polymer Prodrug Nanoparticles Obtained by the Drug-Initiated Method (2014) (25)
- Intracarotidal administration of liposomally-entrapped ATP: improved efficiency against experimental brain ischemia. (1988) (25)
- Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of Action (1993) (25)
- In Vivo Potentialities of EWS‐Fli‐1 Targeted Antisense Oligonucleotides‐Nanospheres Complexes (2005) (25)
- Preparation and characterization of biodegradable poly(isobutylcyano acrylate) nanoparticles with the surface modified by the adsorption of proteins (1995) (25)
- Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections (2019) (25)
- Protein-Functionalized Nanoparticles Derived from End-Functional Polymers and Polymer Prodrugs for Crossing the Blood-Brain Barrier. (2019) (24)
- Unloaded polyisobutylcyanoacrylate nanoparticles: efficiency against bloodstream trypanosomes (1987) (24)
- The Stenlying Effect of High Hydrostatic Pressure on Thermally and Hydrolytically Labile Nanosized Carriers (2003) (24)
- Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route. (2007) (24)
- Squalenoylation of Chitosan: A Platform for Drug Delivery? (2015) (24)
- Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma. (2007) (24)
- Liposomally entrapped adenosine triphosphate. Improved efficiency against experimental brain ischaemia in the rat. (1988) (24)
- Macromolecular Anticancer Therapeutics (2010) (23)
- An aquaporin 4 antisense oligonucleotide loaded, brain targeted nanoparticulate system design. (2014) (23)
- Microcalorimetric investigation on the formation of supramolecular nanoassemblies of associative polymers loaded with gadolinium chelate derivatives. (2009) (23)
- “Squalenoylcurcumin” Nanoassemblies as Water‐Dispersible Drug Candidates with Antileishmanial Activity (2015) (23)
- Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model. (2006) (23)
- Characterization of oligonucleotide/lipid interactions in submicron cationic emulsions: influence of the cationic lipid structure and the presence of PEG-lipids. (2001) (23)
- A comprehensive study on the inclusion mechanism of benzophenone into supramolecular nanoassemblies prepared using two water-soluble associative polymers (2009) (22)
- Synthesis and physicochemical characterization of new squalenoyl amphiphilic gadolinium complexes as nanoparticle contrast agents. (2011) (22)
- Vitamin C–squalene bioconjugate promotes epidermal thickening and collagen production in human skin (2020) (22)
- Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation (2011) (22)
- Quantum dot-loaded PEGylated poly(alkyl cyanoacrylate) nanoparticles for in vitro and in vivo imaging (2011) (22)
- Comparative cell uptake of propidium iodide associated with liposomes or nanoparticles. (1987) (22)
- Multilamellar Nanoparticles Self-Assembled from Opposite Charged Blends: Insights from Mesoscopic Simulation (2015) (22)
- Low-Density Lipoproteins and Human Serum Albumin as Carriers of Squalenoylated Drugs: Insights from Molecular Simulations. (2018) (22)
- Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization. (2011) (21)
- Drug Delivery: Nanoparticles of Metal-Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine (Adv. Mater. 37/2018) (2018) (21)
- Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides. (2012) (21)
- Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis (2015) (21)
- Isobutyl cyanoacrylate nanoparticles as a solid phase for an efficient immunoradiometric assay. (1986) (21)
- Molecular Reactivity of Busulfan Through Its Experimental Electrostatic Properties in the Solid State (2004) (21)
- Consequences of ions and pH on the supramolecular organization of sphingomyelin and sphingomyelin/cholesterol bilayers. (2008) (20)
- New Bicompartmental Structures Are Observed When Stearylamine is Mixed with Triglyceride Emulsions (2000) (20)
- Interfacial deposition of functionalized copolymers onto nanoemulsions produced by the solvent displacement method (2001) (20)
- Liposome-based formulations for the delivery of oligonucleotides (2001) (20)
- Retrovirus budding may constitute a port of entry for drug carriers. (1996) (20)
- Heterotelechelic polymer prodrug nanoparticles: Adaptability to different drug combinations and influence of the dual functionalization on the cytotoxicity (2019) (20)
- Synthesis and Cytotoxic Activity of Self‐Assembling Squalene Conjugates of 3‐[(Pyrrol‐2‐yl)methylidene]‐2,3‐dihydro‐1H‐indol‐2‐one Anticancer Agents (2015) (20)
- Laboratory techniques in biochemistry and molecular biology: An introduction to radioimmunoassay and related techniques: T. Chard (Ed.), Elsevier, Amsterdam, 1990, 290 pp (1991) (20)
- Busulfan loading into poly(alkyl cyanoacrylate) nanoparticles: physico-chemistry and molecular modeling. (2006) (20)
- In‐vitro evaluation of filaricidal activity of GABA and 1,3‐dipalmitoyl‐2‐(4‐aminobutyryl)glycerol HCl: a diglyceride prodrug (1989) (19)
- Pharmaceutical Aspects of Oligonucleotides (2000) (19)
- Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity. (2014) (19)
- Delivery of antisense oligonucleotides by means of pH-sensitive liposomes (1997) (19)
- Towards improved HIV-microbicide activity through the co-encapsulation of NRTI drugs in biocompatible metal organic framework nanocarriers. (2017) (19)
- Effects of silencing the RET/PTC1 oncogene in papillary thyroid carcinoma by siRNA-squalene nanoparticles with and without fusogenic companion GALA-cholesterol. (2014) (19)
- A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy (2018) (19)
- In Vivo FRET Imaging to Predict the Risk Associated with Hepatic Accumulation of Squalene‐Based Prodrug Nanoparticles (2018) (19)
- Novel microparticulate system made of poly(methylidene malonate 2.1.2). (2001) (19)
- Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier. (1996) (18)
- A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary. (2011) (18)
- Efficient Loading and Controlled Release of Benzophenone-3 Entrapped into Self-Assembling Nanogels (2010) (18)
- Original tamoxifen-loaded gels containing cyclodextrins: in situ self-assembling systems for cancer treatment (2004) (18)
- Paraquat detoxication with multiple emulsions. (2009) (18)
- Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry. (2009) (18)
- Supramolecular organization of S12363-liposomes prepared with two different remote loading processes. (2009) (18)
- Plug-in Spectrometry with Optical Fibers as a Novel Analytical Tool for Nanoparticles Technology: Application to the Investigation of the Emulsion Polymerization of the Alkylcyanoacrylate (2003) (18)
- A new generation of polymer nanoparticles for drug delivery. (2010) (18)
- Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide. (2011) (17)
- Involvement of Macrophages in the Pathogenesis of Transmissible Spongiform Encephalopathies (2002) (17)
- Cationic emulsions improves the delivery of oligonucleotides to leukemic P388/ADR cells in ascite. (2003) (17)
- Nanocapsules: Preparation, Characterization and Therapeutic Applications (2006) (17)
- Freeze-drying of squalenoylated nucleoside analogue nanoparticles. (2009) (17)
- Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles. (2019) (16)
- Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate). (2005) (16)
- Nanomedicine: From where are we coming and where are we going? (2019) (15)
- Therapeutic Opportunities in Neuroblastoma Using Nanotechnology (2019) (15)
- Simultaneous use of size-exclusion chromatography and photon correlation spectroscopy for the characterization of poly(lactic acid) nanoparticles (1994) (15)
- Interfacial rheology as a tool to study the potential of cyclodextrin polymers to stabilize oil–water interfaces (2011) (15)
- Study of the Breakup Under Shear of a New Thermally Reversible Water-in-Oil-in-Water (W/O/W) Multiple Emulsion (2001) (15)
- Investigation of the formation of sterically stabilized poly(ethylene glycol/isobutyl cyanoacrylate) nanoparticles by chemical grafting of polyethylene glycol during the polymerization of isobutyl cyanoacrylate (1997) (14)
- Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancreatic cancer. (2018) (14)
- Biodegradable Polymeric Nanoparticles as Drug Carrier for Antitumor Agents (2018) (14)
- Colloidal Carriers: A Promising Way to Treat Central Nervous System Diseases (2009) (14)
- Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers. (2006) (14)
- Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting. (2019) (14)
- Pharmacological manipulation of early PrPres accumulation in the spleen of scrapie-infected mice. (2000) (13)
- Quantitative study of the interaction between polybutylcyanoacrylate nanoparticles and mouse peritoneal macrophages in culture. (1983) (13)
- Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept. (2015) (13)
- N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells. (2003) (13)
- Desmoplastic Reaction in 3D‐Pancreatic Cancer Tissues Suppresses Molecular Permeability (2017) (13)
- In vitro evaluation of nanoparticle formulations containing gangliosides. (1994) (13)
- Synthesis of the orally macrofilaricidal and stable glycerolipidic prodrug of melphalan, 1,3-dipalmitoyl-2-(4'(bis(2''-chloroethyl)amino)phenylalaninoyl)gl ycerol. (1992) (13)
- Etude in vitro de médicaments leishmanicides vectorisés (1993) (13)
- Slow Delivery of the Selective Cholecystokinin Agonist pBC 264 into the Rat Nucleus Accumbens Using Microspheres (1996) (12)
- Liposomes for the delivery of nucleotides and oligonucleotides (1999) (12)
- Squalene-Adenosine Nanoparticles: Ligands of Adenosine Receptors or Adenosine Prodrug? (2019) (12)
- Nanomedicines and stroke: Toward translational research (2015) (12)
- Chapter 1:Historical View of the Design and Development of Nanocarriers for Overcoming Biological Barriers (2012) (12)
- [Polymer nanoparticles for the delivery of anticancer drug]. (2017) (12)
- Combined antitumoral therapy with nanoassemblies of bolaform polyisoprenoyl paclitaxel/gemcitabine prodrugs (2014) (12)
- Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancreatic cancer (2017) (12)
- Surface Pressure and Surface Potential Studies of Poly(Isobutylcyanoacrylate)-Ampicillin Interactions at the Water-Air Interface (1989) (12)
- In vitro and in vivo Evaluation of Poly(Methylidene Malonate 2.1.2) Microparticles Behavior for Oral Administration (2001) (12)
- A new method to isolate polyalkylcyanoacrylate nanoparticle preparations. (1995) (12)
- Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide (2016) (12)
- Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A (2021) (12)
- Strategies to increase the oral bioavailability of nucleoside analogs. (2009) (12)
- Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides. (2018) (11)
- Capillary electrophoresis monitoring of the competitive adsorption of albumin onto the orosomucoid‐coated polyisobutylcyanoacrylate nanoparticles (1994) (11)
- Squalene versus cholesterol: Which is the best nanocarrier for the delivery to cells of the anticancer drug gemcitabine? (2018) (11)
- Synthesis and in Vitro Study of a Diglyceride Prodrug of a Peptide (1994) (11)
- Polymeric Nanoparticles as Drug Carriers (2006) (11)
- Influence of Surface Properties on the Inflammatory Response to Polymeric Nanoparticles (1995) (11)
- Characterization of alginate pregel by rheological investigation (1994) (11)
- New Formulation for the Delivery of Oligonucleotides Using "Clickable" siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes. (2018) (11)
- Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations (2014) (11)
- Swelling of a Sponge Lipid Phase via Incorporation of a Nonionic Amphiphile: SANS and SAXS Studies (2011) (11)
- REACTION OF N-BROMOSUCCINIMIDE WITH NITRILES. II.2, 3 ALIPHATIC NITRILES (1953) (11)
- Dextran-poly-ε-caprolactone micro- and nanoparticles: preparation, characterization and tamoxifen solubilization (2006) (11)
- [The effect of kinetics of water absorption on the disintegration of pharmaceutic tablets with a starch base]. (1976) (11)
- Polymeric Nanoparticles and Microspheres (2018) (10)
- Squalene-based nanoparticles for the targeting of atherosclerotic lesions. (2020) (10)
- Stacking as a Key Property for Creating Nanoparticles with Tunable Shape: The Case of Squalenoyl-Doxorubicin. (2019) (10)
- Propidium-iodide-loaded polyalkylcyanoacrylate particles —labelling conditions and loading capacity (1991) (10)
- Quantification of trimesic acid in liver, spleen and urine by high-performance liquid chromatography coupled to a photodiode-array detection. (2011) (10)
- Retroviral inhibition by antisense oligonucleotides determined by intracellular stability. (1994) (10)
- Influence of the nanoprecipitation conditions on the supramolecular structure of squalenoyled nanoparticles. (2015) (10)
- Application of thermal analysis to the study of lipidic prodrug incorporation into nanocarriers (2009) (9)
- The role of solvent swelling in the self-assembly of squalene based nanomedicines. (2015) (9)
- Busulphan-loaded long-circulating nanospheres, a very attractive challenge for both galenists and pharmacologists (2007) (9)
- Drug delivery: replenishing reservoirs in vivo. (2014) (9)
- Polyisobutylcyanoacrylate nanoparticles as drug carriers : influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin- and doxorubicin-loaded nanoparticles (1998) (9)
- Analysis of Serum Proteins by Micellar Electrokinetic Capillary Chromatography. Application to a Drug Carrier Evaluation (1996) (9)
- [Vectorisation of doxorubicin in nanospheres and reversion of pleiotropic resistance of tumor cells]. (1991) (9)
- Glutathione-loaded poly(isobutylcyanoacrylate) nanoparticles and liposomes: comparative effects in murine erythroleukæmia and macrophage-like cells (2001) (9)
- Monolayer studies on poly(isobutylcyanoacrylate)‐ampicillin association (1987) (9)
- In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. (2016) (9)
- New Poly(Methylidene Malonate 2.1.2) Nanoparticles: Recent Developments (1994) (9)
- [Perspective on the use of microdisperse forms as intracellular vehicles]. (1978) (9)
- Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic. (2010) (9)
- Biology and the Environment (2008) (9)
- pH Sensitive Liposomes as Efficient Carriers for Intracellular Delivery of Oligonucleotides (1996) (8)
- Oral absorption and tissue distribution of a new squalenoyl anticancer nanomedicine (2008) (8)
- Porous Metal–Organic Frameworks as New Drug Carriers (2011) (8)
- [Influence of water penetration on the disintegration of tablets with a starchy base]. (1975) (8)
- PLGA-PEG-supported Pd Nanoparticles as Efficient Catalysts for Suzuki-Miyaura Coupling Reactions in Water. (2016) (8)
- Elongated self-assembled nanocarriers: from molecular organization to therapeutic applications. (2021) (8)
- Lipid-Conjugation of Endogenous Neuropeptides: Improved Biotherapy against Human Pancreatic Cancer (2015) (8)
- Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines (2016) (8)
- In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection. (2012) (8)
- A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine. (2019) (8)
- Atomic pair distribution function (PDF) study of iron oxide nanoparticles in aqueous suspension (2009) (8)
- [Oral tolerance induced by poly (lactide-co-glycolide) containing B lactoglobulin]. (2002) (7)
- [Targeting bone marrow with the help of polyalkylcyanoacrylate nanoparticles]. (1999) (7)
- Synthesis and aqueous organization of 1,3-dipalmitoyl-2-(4-aminobutyryl) glycerol·HCl: a diglyceride prodrug (1991) (7)
- Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release. (2017) (7)
- Oral administration of peptides: Study of a glycerolipidic prodrug (1995) (7)
- Development of Novel Technologies for the Synthesis of Biodegradable Pegylated Nanoparticles (1998) (7)
- Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells (2017) (7)
- Biodegradable polymeric nanoformulation based on the antiprotozoal canthin-6-one (2011) (7)
- A Self-Assembling NHC-Pd-Loaded Calixarene as a Potent Catalyst for the Suzuki-Miyaura Cross-Coupling Reaction in Water (2020) (6)
- Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications. (2008) (6)
- Adenosine and lipids: A forced marriage or a love match? (2019) (6)
- Lipid-Based Anticancer Prodrugs (2010) (6)
- In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin. (1999) (6)
- Squalenoylation: A Novel Technology for Anticancer and Antibiotic Drugs with Enhanced Activity (2016) (6)
- Contribution to the development of oral dosage form for insulin delivery (1999) (6)
- ["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines]. (2009) (6)
- Squalenoyl-gemcitabine/edelfosine nanoassemblies: anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice. (2020) (6)
- Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles. (2009) (6)
- Erratum: Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. (2015) (6)
- (Poly-cyanoacrylate) nanomedicines for cancer and beyond: Lessons learned. (2021) (5)
- Nanoencapsulation of antiviral nucleotide analogs (2009) (5)
- Theoretical and experimental study of beveled thyristor structures (1979) (5)
- Gemcitabine Lipid Prodrugs: The Key Role of the Lipid Moiety on the Self-Assembly into Nanoparticles. (2021) (5)
- Quantification of tetramethyl-terephthalic acid in rat liver, spleen and urine matrices by liquid-liquid phase extraction and HPLC-photodiode array detection. (2012) (5)
- Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma (2020) (5)
- Amphiphilic derivatives of dextran and related nanoparticles (2007) (5)
- Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells. (2015) (5)
- COVID-19 and drugs: pathophysiology and therapeutic approaches. (2021) (5)
- PEGylated Polymer‐Based Nanoparticles for Drug Delivery to the Brain (2011) (5)
- Albumin-driven disassembly of lipidic nanoparticles: the specific case of the squalene-adenosine nanodrug. (2020) (5)
- [Nanoparticles of doxorubicin: colloidal vectors in the treatment of hepatic metastases in animals]. (1989) (5)
- [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres]. (1998) (5)
- Metal-Organic Framework Surface Functionalization: GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness (Small 40/2018) (2018) (4)
- siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma (2007) (4)
- Formulation of Didanosine Prodrugs into PEGylated Poly(alkyl cyanoacrylate) Nanoparticles and Uptake by Brain Endothelial Cells (2009) (4)
- The use of poly (isobutyl cyanoacrylate) nanoparticles with selected antifungal drugs (1987) (4)
- Oil/water “hand-bag like structures”: how interfacial rheology can help to understand their formation? (2005) (4)
- In vitro and in vivo evaluation of macrofilaricidal activity of GABA and 1,3-dipalmitoyl-2-(4-aminobutyryl)glycerol HCl: a diglyceride prodrug. (1992) (4)
- Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography-tandem mass spectrometry in mouse plasma and its application to a pharmacokinetic study. (2015) (4)
- Inhibition of the Friend Retrovirus by Antisense Oligonucleotides. (1992) (4)
- Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies. (2014) (4)
- Biodegradation of Poly(alkylcyanoacrylates) (2002) (4)
- Synthesis and Biopharmaceutical Characterization of Amphiphilic Squalenyl Derivative Based Versatile Drug Delivery Platform (2020) (4)
- Preparation and in vivo studies of a new drug delivery system. Nanoparticles of alkylcyanoacrylate. (1984) (4)
- pH-sensitive liposomes as a carrier for oligonucleotides (ODN) : development of a new methodology to follow physicochemical changes along with pH of native and ODN loaded liposomes (2001) (4)
- Contribution of academic research to discovery and development of medicines: current status and future opportunities (2005) (4)
- Micro- and Nanocarriers for pain alleviation. (2022) (4)
- Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy. (2021) (4)
- Therapeutic Aspects of Liposomes (1990) (3)
- [Monoclonal-antibodies for the Targeting of Drugs] (1984) (3)
- Some physicochemical properties of polyalkylcyanoacrylate nanospheres and nanocapsules (1988) (3)
- Design of nanoparticles for vaccine delivery (1997) (3)
- Delivery of Antisense Oligonucleotides in Vitro (2003) (3)
- About the alleged toxicity of aluminium-based adjuvants in vaccines: all published studies should be taken into account. (2021) (3)
- COMBINING IMAGING AND DRUG DELIVERY FOR THE TREATMENT OF SEVERE DISEASES (2016) (3)
- Comparative in vitro studies on PBN loaded nanoparticles prepared by biodegradable chitosan, PLGA polymers and their PEGylated block copolymers (2014) (3)
- [Nanotechnologies for designing new medicines]. (2012) (3)
- Nanomaterials: Applications in Drug Delivery (2013) (2)
- Gemcitabine lipid prodrug nanoparticles: switching the lipid moiety and changing the fate in the bloodstream. (2021) (2)
- Adsorption of Allergen Extracts onto Colloidal Particles (1994) (2)
- Formulation of glycerolipidic prodrugs into PEGylated liposomes for brain delivery (2009) (2)
- Polymeric Nanoparticles and Microparticles as Carriers for Antisense Oligonucleotides (2000) (2)
- N anoparticles in cancer therapy and diagnosis (2002) (2)
- [Mechanism of disintegration of tablets with a starch base]. (1974) (2)
- [Hybrid nanocarriers for controlled delivery of antitumour and retroviral drugs delivery]. (2010) (2)
- When drug nanocarriers miss their target: extracellular diffusion and cell uptake are not enough to be effective. (2021) (2)
- [Drug vectorization or how to modulate tissular and cellular distribution of biologically active compounds]. (2001) (2)
- Nanoparticles for the Delivery of Peptides and Proteins (1994) (2)
- Modulation Of Nanochannels Hydration In Lipid Cubic Phases Studied by SANS and SAXS (2007) (2)
- ["Carrier" or "modulated distribution" forms, new systems for drug administration]. (1986) (2)
- EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. (2005) (2)
- X-ray microfluorescence for biodistribution studies of nanomedicines. (2017) (2)
- Synthesis of poly(alkyl cyanoacrylate)-based colloidal (2009) (2)
- Poly(alkylcyanoacrylate) Nanoparticles for Nucleic Acid Delivery (2004) (2)
- [Reforming Biosciences and Health Research: Part I, Funding]. (2021) (2)
- PROTECTIVE EFFECTS OF CYSTEAMINE AND CYSTAMINE ON THE IRRADIATED RAT (1964) (2)
- [In vitro study of leishmanicidal agents with drug carriers]. (1993) (2)
- Palladium: a future key player in the nanomedical (2015) (1)
- Liposomes their fate in vivo and their possible therapeutic use (1.V. route). Efficiency of liposome-entrapped ATP in cerebral ischemia (1993) (1)
- [Is energy supply to the brain by ATP possible? Preliminary studies in rats subjected to repeated ischemia]. (1988) (1)
- Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies. (2017) (1)
- Solubility of triacylglycerols or stearylamine in phospholipid vesicles (2004) (1)
- Development of micro- and nanosystems for drug delivery (2008) (1)
- Influence of a non-ionic poloxamer surfactant, Pluronic F68, on protein release from poly(methylidene malonate 2.1.2) microparticles in simulated gastric and intestinal media (2001) (1)
- [ON THE SUBJECT OF PROTECTIVE ACTION OF CYSTEAMINE AND CYSTAMINE IN IRRADIATED RATS]. (1964) (1)
- [Polyalkylcyanoacrylate microspheres: a hepatic vector or a "furtive" vector]. (2000) (1)
- Dossier: Drug delivery and drug efficacy. (2004) (1)
- [The use of nano-particles for the vectorization of antibiotic and antineoplastic drugs]. (1988) (1)
- [The desintegration mechanism of pharmaceutical tablets with starch (author's transl)]. (1976) (1)
- Research Papers Alkylcyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different alkyl chain length (1992) (1)
- Combinatorial Drug Therapy: Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections (Part. Part. Syst. Charact. 3/2019) (2019) (1)
- Doxorubicin-loaded nanoparticles shows increased cytotoxicity efficacy agains hepatocellular carcinoma cells in vitro and in vivo (2002) (1)
- Selective modification of a native protein in a patient tissue homogenate using palladium nanoparticles. (2019) (1)
- The Drug-Initiated Method: A Convenient Approach for the Synthesis of Efficient Polymer Prodrug Nanoparticles. (2015) (1)
- Polymers in Medicine III (1989) (1)
- Nanomedicines and cell-based therapies for embryonal tumors of the nervous system. (2022) (1)
- Cover Picture: Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (Angew. Chem. Int. Ed. 26/2020) (2020) (1)
- Liposomes for the Delivery of Oligonucleotides (2003) (1)
- Biodistribution and anticancer activity of a new vinca alkaloid encapsulated into long-circulating liposomes (2009) (1)
- [Lysosomotropic carriers (author's transl)]. (1980) (1)
- Decoration of Squalenoyl‐Gemcitabine Nanoparticles with Squalenyl‐Hydroxybisphosphonate for the Treatment of Bone Tumors (2021) (1)
- Supramolecular organization and biological interaction of squalenoyl siRNA nanoparticles. (2021) (1)
- Squalenoylation a new concept in drug targeting: evidence of a potent anti-cancer activity of squalenoyl-gemcitabine (2008) (1)
- From Preparation to Real Applications as Drug Delivery Systems (2004) (0)
- Modular Squalene-based Nanosystems (2017) (0)
- Nanoparticles targeting pancreatic tumor. (2014) (0)
- Abstract 2195: Combined strategy based on pre-activated analogs of oxazaphosphorines for increased therapeutic index and immune modulation (2017) (0)
- Galenical form for supply colico active ingredients. (2003) (0)
- Abstract 5702: NanoOxaza, pre-activated oxazaphosphorines prodrugs designed for drug delivery strategy with wide anticancer activity (2012) (0)
- Prodrug Nano-Squalene Bioconjugate Drug Products (2021) (0)
- nanoparticles A process for preparing methylidene malonate nanoparticles optionally containing one or more biologically active molecules and pharmaceutical compositions containing them (1996) (0)
- New copolymers surfactants based on methylidene malonate (1998) (0)
- [Monoclonal antibodies and the targeting of drugs]. (1984) (0)
- Meeting Report: GTRV: 1993 Symposium in Nancy (France) (1994) (0)
- Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. (2012) (0)
- OPTICAL IMAGING AND CHEMOTHERAPY (2016) (0)
- Novel potent doxorubicin derivatives able to self nanoassembly (2011) (0)
- Drugs for colon administration of active ingredients (2003) (0)
- Special JDDST issue in honour of Prof. Dominique Duchêne (2015) (0)
- Abstract 4537: Geranyloxy-ifosfamide: A pre-activated ifosfamide analogue showing an increased therapeutic index (2015) (0)
- New tensioactive copolymers based on methylidene malonate. (1999) (0)
- Material comprises at least one biodegradable polymer and cyclodextrin (2001) (0)
- The fate of therapeutic nanoparticles in a model biological medium: interactions with serum albumin (2019) (0)
- Phospholipid/triglyceride mixtures: analysis and comparison of the solubilisation profiles (2004) (0)
- Incorporation of gemcitabine prodrugs in cyanoacrylate nanospheres and nanocapsules (2003) (0)
- vitamin c complex, said complex nanoparticles, methods for their preparation, their compositions, their uses cosmetics and cosmetic treatment process (2012) (0)
- key for The case of squalenoyl-doxorubicin (0)
- Materials based on biodegradable polymers and process for its preparation (2000) (0)
- Titelbild: Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (Angew. Chem. 26/2020) (2020) (0)
- BIODEGRADABLE PEGYLATED NANOP ARTICLES (1998) (0)
- Drug forms with zellregulierendem factor and / or a promoter for cell proliferation (2001) (0)
- New Enkephalin Nanomedicines for Pain Alleviation, Overcoming the Side Effects of Morphine (2021) (0)
- Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer-by-layer cell coating technology. (2023) (0)
- New microspheres is based on poly (methylidene malonate), their process for the preparation and pharmaceutical compositions containing them (1998) (0)
- Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles (2019) (0)
- Monoclonal-antibodies Coated On Nanoparticles (1983) (0)
- New derivatives of pre-Activated-oxazophorines, use and method of preparation (2010) (0)
- Nanoparticles of gemcitabinderivater (2005) (0)
- Abstract 5671: Enhanced activity of pre-activated oxazaphosphorine prodrugs designed for drug delivery strategy: influence of the length of the engrafted group. (2013) (0)
- Nanoparticules comprenant un poly(cyanoacrylate d'alkyl) et un oligosaccharide cyclique (1999) (0)
- Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation (Eur. J. Org. Chem. 14/2011) (2011) (0)
- Methylidene malonate nanoparticles, methods for their preparation, and pharmaceutical compositions containing them (1997) (0)
- Pharmaceutical form comprising a support material based on methylidene malonate and cell regulation factor (2000) (0)
- Special Section on Drug Delivery Technologies — Minireview Therapeutic Opportunities in Neuroblastoma Using Nanotechnology (2019) (0)
- CONCLUSIONS – RECOMMENDATIONS – FUTURE STRATEGIESAND ACTION PLAN (2009) (0)
- NANO-OBJECTS IN BIOLOGICAL FLUIDS: FROM DETECTION OF ENDOGENOUS VESICLES TO NANOTOXICITY OF EXOGENOUS NANOPARTICLES (2019) (0)
- Targeting of drugs and innovations in drug administration (1999) (0)
- Squalenoyl doxorubicin nanoassemblies: a unique “spaghetti-like” anticancer nanomedicine (2015) (0)
- [Critical study of certain methods using radioiodine for the functional exploration of the thyroid]. (1957) (0)
- Editorial Special edition of International Journal of Pharmaceutics in honor of Professor Dominique Duchêne. (2017) (0)
- Poly(alkylcyanoacrylates): From preparation to real applications as drug delivery systems (2003) (0)
- Effect of Systemic and Intraocular Treatment with Tamoxifen-Loaded Nanoparticles on Experimental Autoimmune Uveoretinitis (EAU) in Lewis Rats (2003) (0)
- A method of sterilizing by high pressure of pharmaceutical compositions in form micro or nanodisperse and compositions thus obtained (2002) (0)
- Squalenoyl Adenosine Nanoparticles and Cerebral Ischemia (2014) (0)
- New biodegradable type surfactants amphiphilic copolymers of hydrophobic segments and oligo and / or polysaccharides (2002) (0)
- New tensidcopolymere on the basis of methylidene malonate (1999) (0)
- Experimental mucosal immunization against a widespread bacterial antigen: phosphorylcholine loaded in microspheres protects mice against pneumococcal pneumonia (1998) (0)
- Characterization of chemoresistant hepatocellular carcinoma in transgenic mice model and cytotoxic activity of novel nanoparticules associated doxorubicin (2001) (0)
- Cancer Nanomedicine (2022) (0)
- Mononuclear Phagocytic System (2001) (0)
- Regulation of Protein Kinase C (PKC) zeta expression in experimental ocular inflammation in Lewis rats (2004) (0)
- A method of forming emulsions based on polymers of cyclodextrin and lipophilic compounds, emulsions thus obtained, and compositions comprising said emulsions (2009) (0)
- United States Patent ( 19 ) Couvreur et al . ( 54 ) PROCESS FOR PREPARING BODEGRADABLE SUBMICROSCOPC PARTICLES CONTAINING A BIOLOGICALLY ACTIVE SUBSTANCE AND THEIR USE (2017) (0)
- 11. CONCLUSIONS - RECOMMENDATIONS - FUTURE STRATEGIES AND ACTION PLAN (2011) (0)
- Organic and inorganic hybrid nanoparticles based on iron carboxylates (2008) (0)
- Electrophoretic pattern of sera of normal and cancer patients. (1972) (0)
- Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells (2017) (0)
- Plasma membrane lipid bilayer is druggable: Selective delivery of gemcitabine-squalene nano-medicine to cancer cells. (2023) (0)
- A method for producing particles of submicroscopic, thus obtained particles and pharmaceuticals containing the particles. (1982) (0)
- Abstract B33: PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma (2017) (0)
- New potent anticancer nanoassembly from squalenoylation platform: doxorubicin derivative. (2011) (0)
- SC16 stimulation of the mucosal immune response by a thyroglobulin-phosphorylcholine conjugate entrapped in PLA-GA microspheres (1994) (0)
- New cationic copolymers, their use for the vectorization of biomolecules, their intermediate of synthesis (2003) (0)
- Oxazaphosphorines novel preactivated, use and method of preparation (2011) (0)
- Chemistry and medicine: What the COVID-19 epidemic has taught us (2020) (0)
- Nanoparticles derivative of gemcitabine (2004) (0)
- Squalenoylation of chitosan : a new platform for anti-infectives delivery ? (2015) (0)
- Investigation of squalenoylated doxorubicin interactions within living cancer cells using near infrared Raman microspectroscopy (2016) (0)
- Antisense oligonucleotides in cancerology (1997) (0)
- The Delivery of Oligonucleotides Using pH Sensitive Liposomes (2017) (0)
- Adenosine delivery via squalene-adenosine nanoparticles to treat ischemic diseases: liver versus brain (2018) (0)
- Trends in the development of oral anticoagulants. (2015) (0)
- Ultrasound-triggered pain relief (2017) (0)
- Nanoparticles of therapeutic assets of low aqueous solubility (2007) (0)
- Mechanisms of Transmembrane Transport of Oligonucleotides (2003) (0)
- Well-defined material for making particulate vectors for therapeutic or diagnostic agents, comprises biodegradable polymer and covalently grafted polysaccharide (2000) (0)
- Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application (2022) (0)
- Nanoparticles the polyisobutylcyanoacrylate and cyclodextrins contain (1999) (0)
- Nanoparticles comprising poly (isobutyl cyanoacrylate) and cyclodextrins. (1999) (0)
- How terpene-based nanoparticles , harboring stimuli-responsive linker , overcome poor diffusion of β-lactam antibiotic to treat intracellular infection ? (2014) (0)
- dosage form for the issuance of colic active (2002) (0)
- Squalene-doxorubicin: nanoassembly with superior anticancer activity and reduced toxicity. (2011) (0)
- Ultrasound-triggered pain relief (2017) (0)
- 1 Comparative In Vitro Studies on PBN Loaded Nanoparticles Prepared by Biodegradable 1 Chitosan , PLGA Polymers and Their PEGylated Block Copolymers 2 3 (2018) (0)
- Targeted nanoparticles for pancreatic cancer. (2013) (0)
- [Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease]. (2012) (0)
- inorganic organic hybrid nanoparticles based on iron carboxylates. (2007) (0)
- 1 Supporting information for Role of Solvent Swelling in Self-Assembly of Squalene based Nanomedicines (2015) (0)
- Correction: Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications (2023) (0)
- Nanoparticules de derives de la gemcitabine (2005) (0)
- [Specificity of anticancer treatment:aims and limits of targeting. I. Targeting carriers]. (1986) (0)
- Composite polymeric nanoparticles (2004) (0)
- Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A (2021) (0)
- P oly ( alkylcyanoacrylates ) as biodegradable materials for biomedical applications (2003) (0)
- Abstracts of Dutch doctoral theses (2005) (0)
- New transfer system for nucleic acid (2008) (0)
- Patrick Couvreur: inspiring pharmaceutical innovation (2014) (0)
This paper list is powered by the following services:
Other Resources About Patrick Couvreur
What Schools Are Affiliated With Patrick Couvreur?
Patrick Couvreur is affiliated with the following schools:
